Palladium Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $373K | Buy |
3,687
+100
| +3% | +$10.5K | 0.02% | 267 |
|
|
2021
Q4 | $370K | Sell |
3,587
-637
| -15% | -$58.9K | 0.02% | 272 |
|
|
2021
Q3 | $358K | Buy |
4,224
+382
| +10% | +$32K | 0.02% | 239 |
|
|
2021
Q2 | $321K | Sell |
3,842
-134
| -3% | -$11K | 0.02% | 238 |
|
|
2021
Q1 | $299K | Buy |
3,976
+119
| +3% | +$8.67K | 0.01% | 240 |
|
|
2020
Q4 | $263K | Buy |
3,857
+262
| +7% | +$17K | 0.01% | 230 |
|
|
2020
Q3 | $210K | Buy |
3,595
+299
| +9% | +$18.6K | 0.01% | 236 |
|
|
2020
Q2 | $214K | Buy |
+3,296
| New | +$208K | 0.01% | 235 |
|
|
2020
Q1 | – | Sell |
-3,378
| Closed | -$251K | – | 245 |
|
|
2019
Q4 | $251K | Sell |
3,378
-995
| -23% | -$69.9K | 0.02% | 239 |
|
|
2019
Q3 | $344K | Sell |
4,373
-2,644
| -38% | -$157K | 0.02% | 211 |
|
|
2019
Q2 | $382K | Sell |
7,017
-874
| -11% | -$47.1K | 0.03% | 208 |
|
|
2019
Q1 | $426K | Sell |
7,891
-3,016
| -28% | -$186K | 0.03% | 200 |
|
|
2018
Q4 | $714K | Buy |
10,907
+6,534
| +149% | +$488K | 0.06% | 163 |
|
|
2018
Q3 | $344K | Sell |
4,373
-2,136
| -33% | -$153K | 0.02% | 221 |
|
|
2018
Q2 | $419K | Sell |
6,509
-13,482
| -67% | -$888K | 0.03% | 206 |
|
|
2018
Q1 | $1.24M | Sell |
19,991
-59,950
| -75% | -$4.3M | 0.09% | 141 |
|
|
2017
Q4 | $5.8M | Sell |
79,941
-2,238
| -3% | -$163K | 0.42% | 62 |
|
|
2017
Q3 | $6.68M | Buy |
82,179
+1,757
| +2% | +$139K | 0.51% | 57 |
|
|
2017
Q2 | $6.47M | Buy |
80,422
+10,363
| +15% | +$818K | 0.51% | 55 |
|
|
2017
Q1 | $5.5M | Buy |
70,059
+66,760
| +2,024% | +$5.33M | 0.44% | 62 |
|
|
2016
Q4 | $261K | Sell |
3,299
-285
| -8% | -$23.1K | 0.02% | 222 |
|
|
2016
Q3 | $319K | Sell |
3,584
-140
| -4% | -$13.2K | 0.03% | 208 |
|
|
2016
Q2 | $356K | Buy |
3,724
+38
| +1% | +$3.79K | 0.03% | 193 |
|
|
2016
Q1 | $383K | Sell |
3,686
-373
| -9% | -$36.3K | 0.04% | 191 |
|
|
2015
Q4 | $397K | Buy |
4,059
+100
| +3% | +$9.79K | 0.04% | 194 |
|
|
2015
Q3 | $382K | Sell |
3,959
-200
| -5% | -$21K | 0.04% | 187 |
|
|
2015
Q2 | $436K | Sell |
4,159
-200
| -5% | -$20.4K | 0.04% | 197 |
|
|
2015
Q1 | $450K | Sell |
4,359
-199
| -4% | -$20.1K | 0.04% | 199 |
|
|
2014
Q4 | $439K | Buy |
4,558
+150
| +3% | +$13.2K | 0.04% | 202 |
|
|
2014
Q3 | $351K | Buy |
4,408
+76
| +2% | +$5.99K | 0.03% | 208 |
|
|
2014
Q2 | $326K | Buy |
4,332
+700
| +19% | +$52.9K | 0.03% | 215 |
|
|
2014
Q1 | $272K | Sell |
3,632
-338
| -9% | -$23.9K | 0.02% | 227 |
|
|
2013
Q4 | $284K | Hold |
3,970
| – | – | 0.03% | 226 |
|
|
2013
Q3 | $225K | Hold |
3,970
| – | – | 0.02% | 230 |
|
|
2013
Q2 | $227K | Buy |
+3,970
| New | +$230K | 0.02% | 226 |
|
Other funds holding CVS
Palladium Partners's CVS Position: Q1 2022 in Review
Palladium Partners increased its CVS Health (CVS) stake by 2.8% in Q1 2022, buying an estimated $10.5K and bringing the position to 3,687 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #267.
Palladium Partners first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $6.68M in Q3 2017. 2,366 funds tracked by Wall St. Rank hold CVS as of Q1 2022.
- Palladium Partners held 3,687 shares of CVS Health worth $373K as of Q1 2022.
- Palladium Partners bought 100 CVS Health shares in Q1 2022, an estimated $10.5K.
- CVS Health made up 0.02% of Palladium Partners's portfolio in Q1 2022, its #267 holding.
- Palladium Partners first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
- Palladium Partners's CVS Health position peaked at $6.68M in Q3 2017.
- 2,366 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.